1. Home
  2. NRDS vs YDES Comparison

NRDS vs YDES Comparison

Compare NRDS & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NerdWallet Inc.

NRDS

NerdWallet Inc.

HOLD

Current Price

$9.54

Market Cap

631.6M

Sector

Technology

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$4.10

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRDS
YDES
Founded
2009
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
631.6M
543.0M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
NRDS
YDES
Price
$9.54
$4.10
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
621.4K
174.8K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
68.42
N/A
EPS
0.37
N/A
Revenue
$836,600,000.00
N/A
Revenue This Year
$10.13
N/A
Revenue Next Year
$7.11
N/A
P/E Ratio
$26.70
N/A
Revenue Growth
21.67
N/A
52 Week Low
$7.33
$1.70
52 Week High
$16.24
$25.00

Technical Indicators

Market Signals
Indicator
NRDS
YDES
Relative Strength Index (RSI) 46.13 57.16
Support Level $9.26 $1.99
Resistance Level $9.75 $5.15
Average True Range (ATR) 0.28 0.84
MACD -0.05 -0.09
Stochastic Oscillator 3.68 49.21

Price Performance

Historical Comparison
NRDS
YDES

About NRDS NerdWallet Inc.

Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. The Company's platform comprises three primary components: Editorial and Content Publishing, Marketplace and Referral Services, and Financial Services. It operates in the United States, Canada, and the United Kingdom.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: